Highlights Merck & Co., Inc.

Equities

MRK

US58933Y1055

Pharmaceuticals

Market Closed - Nyse Other stock markets 16:00:02 2025-06-13 EDT			After hours 20:00:00
81.71 ^USD	-0.13%		81.00	-0.87%

06-13	Global markets live: Tesla, Google, Apple, Novo Nordisk, Boeing…
06-13	Merck: FDA approves Keytruda for head and neck cancer	CF

Highlights

FDA Approves Merck's Anti-PD-1 Therapy	06-13	CI
US Senators Introduce Bill to Ban Direct-to-Consumer Drug Ads	06-12	MT
BioNTech takes over CureVac in $1.25 billion all-stock deal among COVID rivals	06-12	RE
Merck Initiates Phase 3 Study Evaluating Dengue Vaccine Candidate	06-12	CI
Worldwide Healthcare Trust trails benchmark in "challenging" year	06-11	AN
Insmed's drug for rare lung disease achieves 'home run' in mid-stage trial	06-10	RE
US FDA approves Merck's RSV antibody for infants	06-09	RE
US FDA approves Merck's RSV antibody for infants	06-09	RE
Merck Announces U.S. Food and Drug Administration Approve Enflonsia? (Clesrovimab-Cfor)	06-09	CI
Merck: positive Phase 3 results in hyperlipidemia	06-09	CF
Exchange-Traded Funds, Equity Futures Higher Pre-Bell Monday Ahead of US-China Trade Talks	06-09	MT
Merck Announces Positive Topline Results from the First Two Phase 3 CORALreef Trials Evaluating Enlicitide Decanoate for the Treatment of Adults with Hyperlipidemia	06-09	CI
EMA PRAC's Reviewing Risk Of Encephalitis With Two Varicella Vaccines	06-06	RE
Alvotech, Dr. Reddy's Partner to Develop Keytruda Biosimilar Candidate	06-05	MT
Deals of the day-Mergers and acquisitions	06-03	RE
Sector Update: Health Care	06-03	MT
Merck Held Talks to Buy MoonLake for Over $3 Billion; MoonLake Shares Rise	06-03	MT
Deals of the day-Mergers and acquisitions	06-03	RE
Merck Held Talks to Buy MoonLake for Over $3 Billion; MoonLake Shares Rise Pre-Bell	06-03	MT
Deals of the day-Mergers and acquisitions	06-03	RE
PRESS DIGEST- Financial Times - June 3	06-02	RE
Merck Reportedly Held Talks to Buy MoonLake for over $3B	06-02	CI
Merck held talks to buy biotech MoonLake for over $3 billion, FT reports	06-02	RE
Merck held talks to buy biotech MoonLake for over $3 billion, FT reports	06-02	RE
Merck held talks to buy biotech MoonLake for over $3 billion, FT reports	06-02	RE

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Merck & Co., Inc.

Equities

MRK

US58933Y1055

Pharmaceuticals

Highlights

Filters